PATENT CLAIM ANALYSIS

Application Number: 16033636
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2020-01
Patent Classification: ["514", "210180"]

Abstract:
Compounds of structural Formula I were developed for the treatment of infections by filoviruses including Ebolavirus and Marburgvirus, wherein, R 1 , R 2 , R 3 , X and Y are defined in the specification.

Claim (Index 39):
The compound of  claim 38  selected from the group consisting of

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12702937', '13091895', '09669298', '11034635', '13121900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8252687072073925
- 35 USC 102 Novelty (BERT): 0.5727246844121857
- Combined Prediction Score: 0.8000143049278718
- Mean Citation Score: 332.16656
- Max Citation Score: 360.32703
- Similarity Product: 167.153314461599

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test